MorphoSys to Present at Six Upcoming Conferences
(Thomson Reuters ONE) -
MorphoSys AG /
MorphoSys to Present at Six Upcoming Conferences
. Processed and transmitted by NASDAQ OMX Corporate Solutions.
The issuer is solely responsible for the content of this announcement.
MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX; OTC: MPSYY) will present
at the following conferences:
MorphoSys Investor & Analyst Event at ASCO 2016:
Date: June 6, 2016, 6:30 p.m. CDT (June 7, 2016, 0:30 a.m. BST, 1:30 a.m. CEST)
Venue: Chicago, IL, USA
Presenter: Dr. Simon Moroney, Chief Executive Officer of MorphoSys AG
Dr. Arndt Schottelius, Chief Development Officer of MorphoSys AG
Dr. Claudia Gutjahr-Löser, Head of Corporate Communications & IR
Goldman Sachs 37th Annual Global Healthcare Conference
Date: June 7, 2016, 3:20 p.m. PDT (11:20 p.m. BST, June 8, 2016, 0:20 a.m. CEST)
Venue: Rancho Palos Verdes, CA, USA
Presenter: Dr. Simon Moroney, Chief Executive Officer of MorphoSys AG
Dr. Claudia Gutjahr-Löser, Head of Corporate Communications & IR
dbAccess German, Swiss & Austrian Conference
Date: June 9, 2016, 8:00 a.m. CEST (7:00 a.m. BST, 2:00 a.m. EDT)
Venue: Berlin, Germany
Presenter: Jens Holstein, Chief Financial Officer of MorphoSys AG
Jefferies 2016 Global Health Care Conference
Date: June 10, 2016, 1:00 p.m. EDT (6:00 p.m. BST, 7:00 p.m. CEST)
Venue: New York, NY, USA
Presenter: Dr. Simon Moroney, Chief Executive Officer of MorphoSys AG
Dr. Claudia Gutjahr-Löser, Head of Corporate Communications & IR
9th DVFA Life Science Conference
Date: June 14, 2016, 1:30 p.m. CEST (12:30 p.m. BST, 7:30 a.m. EDT)
Venue: Frankfurt am Main, Germany
Presenter: Dr. Simon Moroney, Chief Executive Officer of MorphoSys AG
Jochen Orlowski, Associated Director, Corporate Communications & IR
J.P. Morgan European Healthcare Conference
Date: June 23, 2016
Venue: London, UK
Presenter: Jens Holstein, Chief Financial Officer of MorphoSys AG
Dr. Claudia Gutjahr-Löser, Head of Corporate Communications & IR
A PDF version of all presentations will be provided at www.morphosys.com.
The link to webcasts will be filed under www.morphosys.com/conference-calls.
The Annual General Meeting of MorphoSys AG will take place on June 2, 2016 in
Munich. A live webcast of the event and all related information are available on
www.morphosys.com/agm.
About MorphoSys:
MorphoSys developed HuCAL, the most successful antibody library technology in
the pharmaceutical industry. By successfully applying this and other patented
technologies, MorphoSys has become a leader in the field of therapeutic
antibodies, one of the fastest-growing drug classes in human healthcare.
Together with its pharmaceutical partners, MorphoSys has built a therapeutic
pipeline of more than 100 human antibody drug candidates for the treatment of
cancer, rheumatoid arthritis, and Alzheimer's disease, to name just a few. With
its ongoing commitment to new antibody technology and drug development,
MorphoSys is focused on making the healthcare products of tomorrow. MorphoSys is
listed on the Frankfurt Stock Exchange under the symbol MOR. For regular updates
about MorphoSys, visit http://www.morphosys.com.
HuCAL®, HuCAL GOLD®, HuCAL PLATINUM®, CysDisplay®, RapMAT®, arYla®, Ylanthia®,
100 billion high potentials®, Slonomics®, Lanthio Pharma® and LanthioPep® are
registered trademarks of the MorphoSys Group.
This communication contains certain forward-looking statements concerning the
MorphoSys group of companies, The forward-looking statements contained herein
represent the judgment of MorphoSys as of the date of this release and involve
risks and uncertainties, Should actual conditions differ from the Company's
assumptions, actual results and actions may differ from those anticipated,
MorphoSys does not intend to update any of these forward-looking statements as
far as the wording of the relevant press release is concerned
For more information, please contact:
MorphoSys AG
Dr. Claudia Gutjahr-Löser
Head of Corporate Communications & IR
Alexandra Goller
Senior Manager Corporate Communications & IR
Jochen Orlowski
Associate Director Corporate Communications & IR
Tel: +49 (0) 89 / 899 27-404
investors(at)morphosys.com
Conference Announcement (PDF):
http://hugin.info/130295/R/2016917/748202.pdf
This announcement is distributed by GlobeNewswire on behalf of
GlobeNewswire clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: MorphoSys AG via GlobeNewswire
[HUG#2016917]
Unternehmensinformation / Kurzprofil:
Datum: 01.06.2016 - 14:01 Uhr
Sprache: Deutsch
News-ID 475027
Anzahl Zeichen: 5320
contact information:
Town:
Martinsried / Munich
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 248 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"MorphoSys to Present at Six Upcoming Conferences"
steht unter der journalistisch-redaktionellen Verantwortung von
MorphoSys AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
